narmac, on June 27, 2013, we closed at $0.23 CAN. The year low (52-week low) is $0.385 as of last Friday. Year high is $0.95.

I'm still keeping my hopes up of RVX succeeding in the COVID 19 clinical trial. That will put a feather in our cap, and hopefully bring in a third major partner even though the effect of COVID 19 is simmering. COVID 19 will be around for years to come. 

Glass half full ... Koo :)